Publications by authors named "Tongqi Ge"

Claim this Profile
T
Targeting the C5-C5aR1 axis: A promising therapeutic strategy for Alzheimer's disease and amyotrophic lateral sclerosis by unlocking neuroprotection.
Tong-Qi Ge, Pu Wang, Pei-Pei Guan

Biochem Pharmacol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aspirin Attenuates the Pathogenesis of Amyotrophic Lateral Sclerosis by Inhibiting the Activities of Microglia in a NF-κB-dependent Complement System-deactivating Mechanism.
Tong-Qi Ge, Xiao-Yuan Ma, Pei-Pei Guan, Pu Wang

Mol Neurobiol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complement 3a induces the synapse loss via C3aR in mitochondria-dependent NLRP3 activating mechanisms during the development and progression of Alzheimer's disease.
Tong-Qi Ge, Pei-Pei Guan, Pu Wang

Neurosci Biobehav Rev· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
As a Potential Therapeutic Target, C1q Induces Synapse Loss Via Inflammasome-activating Apoptotic and Mitochondria Impairment Mechanisms in Alzheimer's Disease.
Pei-Pei Guan, Tong-Qi Ge, Pu Wang

J Neuroimmune Pharmacol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Artesunate: A natural product-based immunomodulator involved in human complement.
Lihong Song, Tongqi Ge, Zeqin Li, Jinfeng Sun, Gao Li

Biomed Pharmacother· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis